Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.
A commercial kit assay of tartrate-resistant acid phosphatase (TRACP 5b) used for the diagnosis of bone resorption was modified with a 'Fit-For-Purpose' approach for drug development of anti-resorptive therapeutics. The modifications included changing the standard matrix from buffer to serum, using a consistent bulk reference material to prepare standards and quality controls (QC), and adding sample controls (SC) prepared from authentic sample pools. Method validation experiments were conducted for: inter- and intra-assay accuracy and precision, establishment of SC, range finding of different population groups, selectivity tests, parallelism and stability. The analytical range was 1.00-10.0 U/L and the total errors of lower limit of quantification (LLOQ) and upper limit of quantification (ULOQ) validation samples were 8% and 21%, respectively. Data of range finding experiment showed that serum samples should be collected in tubes instead of bags. Selectivity results showed accurate spike recovery among the majority of test samples from target populations. Samples were demonstrated to be stable for up to four freeze/thaw cycles and for 24 months at -70+/-10 degrees C. Our results show that the modified TRACP 5b method is reliable for the quantification of TRACP 5b in human serum samples to support clinical trials of bone resorptive effect reflected by TRACP 5b activities. The method was robust with similar assay performance characteristics shown in three bioanalytical laboratories.
Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, CA 91320, USA. wuyu@MedImmune.com
Yuling
Y
Wu
Jean W
JW
Lee
Lennie
L
Uy
Bassam
B
Abosaleem
Han
H
Gunn
Mark
M
Ma
Binodh
B
DeSilva
D000135:Acid Phosphatase / Q000097:blood*; D001681:Biological Assay; D015415:Biomarkers / Q000097:blood; D001862:Bone Resorption / Q000175:diagnosis*; D001842:Bone and Bones / Q000737:chemistry; D002021:Buffers; D002138:Calibration; D004355:Drug Stability; D005260:Female; D005615:Freezing; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D007700:Kinetics; D008297:Male; D011786:Quality Control; D011933:Reagent Kits, Diagnostic; D011994:Recombinant Proteins / Q000737:chemistry; D012015:Reference Standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D000071681:Tartrate-Resistant Acid Phosphatase; D013997:Time Factors
D015415:Biomarkers; D002021:Buffers; D007527:Isoenzymes; D011933:Reagent Kits, Diagnostic; D011994:Recombinant Proteins; C000605510:ACP5 protein, human; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase